Family Medicine: Look Back, Move Forward
Take another look at these highlights of 2024 in family medicine as you look forward to 2025. It includes health policy, practice tools, your well-being, improved health equity, and more.
Related Articles
Wisp Teams Up with Nourish to Combine GLP-1s with Nutrition Counseling – MedCity News
Wisp patients enrolled in its weight care program can now access nutrition counseling services with Nourish.
Ralph and Kathy Pounds Reflect on Their 30-Year Philanthropic Journey
Ralph and Kathy Pounds have generously given to areas including individualized medicine, biomedical research and junior faculty development.
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype | NEJM
Depemokimab is an ultra-long-acting biologic therapy with enhanced binding affinity for interleukin-5 that may enable effective 6-month dosing intervals. In these phase 3A, randomized, placebo-cont…
Evolution of HER2-Targeted Therapy in Biliary Tract Cancer
Do you know which type of biliary tract cancer (BTC) has the highest rate of HER2 aberrations?
Most Effective Treatments for Adult ADHD Identified
Results of a large meta-analysis revealed the most effective treatments for reducing the core symptoms of adult ADHD.
Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination | NEJM
At the beginning of the 2018–2020 outbreak of Ebola virus disease (EVD) in eastern Democratic Republic of Congo (DRC), no vaccine had been licensed. However,…
Health Rounds: J&J drug helps delay multiple myeloma in high-risk patients
The Johnson & Johnson drug Darzalex showed promise in helping keep a precancerous condition from progressing to the blood cancer multiple myeloma for those at…
Why You Have a Sore Throat in the Morning
An otolaryngologist explains the reasons you might wake up in the morning with a sore throat, what to do about it and when it’s time…
A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis
Data from randomized trials evaluating the effectiveness of tuberculosis (TB) preventive treatment for contacts of multidrug-resistant (MDR)-TB are lacking. Two recently published randomized trials…
Levofloxacin Preventive Therapy for Persons Exposed to MDR Tuberculosis | NEJM
The use of preventive tuberculosis treatment after Mycobacterium tuberculosis infection, historically with isoniazid and more recently with shorter-duration rifamycin regimens, is a core component …